Author

S. Holdenrieder

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

C. Hagen· 1 shared E. Bartok· 1 shared G. Hartmann· 1 shared J. G. van den Boorn· 1 shared M. Renn· 1 shared M. Schlee· 1 shared P. Müller· 1 shared S. Garbe· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Hagen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivOct 16, 2021

RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma

S. Lambing, S. Holdenrieder, P. Müller…·M. Renn

This study shows that RIG-I ligands enhance radiation-induced tumor cell death and immunogenicity in melanoma, with p53 playing a key role in the synergy between RIG-I and radiation.

DOI 10.1093/jmcb/mjad001

humanmouse

𝕏 PostBluesky